Screening for liver cancer: the rush to judgment

Area of Science:

• Hepatology
• Medical Imaging
• Oncology

Background:

• A 2005 recommendation advised monthly ultrasonography for hepatocellular carcinoma (HCC) screening in 3 million Americans with cirrhosis.
• This guideline was based on a Chinese randomized trial involving hepatitis B surface antigen carriers.

Purpose of the Study:

• To critically evaluate the evidence supporting the recommendation for routine HCC screening.
• To highlight the limitations of the foundational Chinese trial and its applicability to the American population.

Main Methods:

• Review of the methodology and reported outcomes of the Chinese randomized trial.
• Analysis of potential biases and limitations, including population differences and statistical reporting.

Main Results:

• The Chinese trial's findings may not be generalizable to the American population due to significant differences.
• Methodological concerns, including incomplete death reporting and exclusion of patients post-randomization, cast doubt on the trial's validity.
• Failure to account for cluster randomization likely inflated the observed benefits.

Conclusions:

• The effectiveness of routine ultrasonography for HCC screening in cirrhotic patients remains unproven.
• Further high-quality randomized trials are necessary to establish optimal screening protocols and ensure patient care.